Straits Times Index
3,281.05 -6.70 (-0.20%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,668.29 +383.75 (+2.22%) FTSE 100
8,129.18 +50.32 (+0.62%) Bitcoin USD
64,296.63 -66.78 (-0.10%) CMC Crypto 200
1,388.47 -8.06 (-0.58%)
Ardelyx Inc (41X.SG)
| Previous close | 5.86 |
| Open | 5.90 |
| Bid | 5.83 x 0 |
| Ask | 5.97 x 0 |
| Day's range | 5.82 - 6.05 |
| 52-week range | 2.97 - 9.46 |
| Volume | |
| Avg. volume | 450 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksArdelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Ardelyx (ARDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simply Wall St.Ardelyx's (NASDAQ:ARDX) investors will be pleased with their favorable 91% return over the last five years
While Ardelyx, Inc. ( NASDAQ:ARDX ) shareholders are probably generally happy, the stock hasn't had particularly good...
GlobeNewswireArdelyx to Report First Quarter 2024 Financial Results on May 2, 2024
Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, May 2, 2024, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the first quarter of 2024. To part
